Novartis Oncology Director of Finance Salary | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Director of Finance Salary

The average Novartis Oncology Director of Finance earns an estimated $140,442 annually. Novartis Oncology's Director of Finance compensation is $21,574 less than the US average for a Director of Finance.

The Finance Department at Novartis Oncology earns $23,951 more on average than the Admin Department.

Last updated 3 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$140,442
Average Compensation
$140,442
avg. base

Director of Finance Salaries at Novartis Oncology

Directors of Finance earn $35,736 more than Accounting Managers.

Accounting Manager
$105k*
Business Analyst
$92k*
Financial Analyst
$92k*
Senior Accountant
$90k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

The Finance Department averages $23,951 more than the Admin Department, and $6,796 less than the Operations Department

Operations
$90,563 Avg. total comp.
+$7k
Finance
$83,767 Avg. total comp.
Admin
$59,816 Avg. total comp.
-$24k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Novartis Oncology reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Novartis Oncology reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Novartis Oncology Rate Their Compensation

The majority of Directors of Finance at Novartis Oncology believe they're not compensated fairly. 100% of Directors of Finance at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company